Sintilimab Plus Bevacizumab as Adjuvant Therapy in HCC Patients at High Risk of Recurrence After Curative Resection
- Status
- UNKNOWN
- Phase
- PHASE3
Clinical Trials Related to Bevacizumab
Related studies linked through entity extraction aliases.
Recurrent GBM Treated With Neurosurgical Resection and IORT Using the Xoft Axxent eBx System and Bevacizumab
- Status
- TERMINATED
- Phase
- PHASE2
Trial on NIraparib-TSR-042 (Dostarlimab) vs Physician's Choice CHEmotherapy in Recurrent, Ovarian, Fallopian Tube or Primary Peritoneal Cancer Patients Not Candidate for Platinum Retreatment
- Status
- UNKNOWN
- Phase
- PHASE3
A Study of Atezolizumab With or Without Bevacizumab in Combination With Cisplatin Plus Gemcitabine in Patients With Untreated, Advanced Biliary Tract Cancer
- Status
- COMPLETED
- Phase
- PHASE2
An Open Label Study Evaluating the Efficacy and Safety of Etrumadenant (AB928) Based Treatment Combinations in Participants With Metastatic Colorectal Cancer.
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study to Evaluate Efficacy and Safety of Selective Internal Radiation Therapy Plus Xelox, Bevacizumab and Atezolizumab (Immune Chekpoint Inhibitor) in Patients With Liver-dominant Metastatic Colorectal Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
A Randomized Trial of Low-Dose Bevacizumab vs Laser for Type 1 ROP
- Status
- TERMINATED
- Phase
- PHASE3
Bevacizumab Treatment For Type 1 ROP
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
HAIC Combined With Bevacizumab and Toripalimab for Advanced Hepatocellular Carcinama
- Status
- UNKNOWN
- Phase
- PHASE2
A Trial to Find Out How Safe REGN7075 is and How Well it Works in Combination With Cemiplimab for Adult Participants With Advanced Cancers
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Early-Line Anti-EGFR Therapy to Facilitate Retreatment for Select Patients With mCRC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Bevacizumab Plus EGFR-TKIs in Chinese Patients With EGFR-mutant NSCLC: a Real-world Study
- Status
- UNKNOWN
- Phase
- N/A
ONO-4538 Phase II Rollover Study (ONO-4538-98)
- Status
- RECRUITING
- Phase
- PHASE2
Trifluridine/Tipiracil in Combination With Capecitabine and Bevacizumab in Metastatic Colorectal Cancer Patients.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
An Exploratory Study of Atezolizumab and Bevacizumab in Hepatocellular Carcinoma and Non-Small Cell Lung Cancer With Liver Metastases (INTEGRATE)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Efficacy and Safety of Niraparib Combined With Bevacizumab in Platinum Refractory/Resistant Recurrent Ovarian Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Bintrafusp Alfa Combination Therapy in Participants With Cervical Cancer (INTR@PID 046)
- Status
- COMPLETED
- Phase
- PHASE1
Study of Atezolizumab and Bevacizumab With Y-90 TARE in Patients With Unresectable Hepatocellular Carcinoma (HCC)
- Status
- TERMINATED
- Phase
- PHASE2
QL1101 in Combination With JS001 in Patients With pMMR/MSS Refractory Metastatic Colorectal Cancer
- Status
- UNKNOWN
- Phase
- PHASE2